Behind Glass: What Cdmo Leadership Really Demands With Joerg Ahlgrimm
In this episode of the Active Ingredients podcast, host Thomas Dove interviews Joerg Ahlgrimm, Chief Executive Officer (CEO) of SK Pharmteco. Joerg Ahlgrimm has led global manufacturing networks at Baxter and Lonza, founded the gene therapy contract development and manufacturing organisation (CDMO) Centre for Breakthrough Medicines during COVID, and now leads SK Pharmteco’s global operations from the United States. In this conversation, he explains why listening, strategy, and fast decision-making remain his three active ingredients of leadership. He shares what changed when he moved from an innovator company to CDMO life, why trust takes years to build and one event to destroy, and how growing up in East Germany shaped his focus on community. Key Takeaways · Explore why CDMO leadership means working “behind glass”, where every deviation and delay is visible to the customer, leaving no safety cushion. · Understand what changes when senior leaders move from an innovator pharmaceutical company into a CDMO, where commercial skill matters as much as operations. · Apply Ahlgrimm’s view on trust: one bad quality result can undo years of goodwill, so proactive communication is as important as getting it right the first time. · Learn why listening, not authority, is Ahlgrimm’s first active ingredient of leadership, since assuming you already know everything is a big trap. · Discover why Ahlgrimm calls himself an “80% guy”. Chasing full certainty before deciding costs speed, and you still make errors regardless. · Gain insight into building a gene therapy CDMO from near nothing, with payroll run hand to mouth before financing closed on Christmas Eve. · Uncover how growing up without freedom of travel or speech in East Germany shaped Ahlgrimm’s lasting belief in community. · Identify why a strong support network, from family to team, carries executives through the loneliest stretches of building something new. · Take away Ahlgrimm’s advice for the next generation: learn the fundamentals broadly, put the patient first, and let results follow. Snippets · “Trust is something which you can’t earn in a very short transactional relationship… It takes a week, or one event, which destroys the trust, and it takes months and years to rebuild it.” · “If you believe that you are a good ops guy in the innovator world, and now you just replicate this to the CDMO world, I think you will fail.” · “Never forget that you will never achieve results by your own work. You will always achieve the results by everybody’s contributions.” Timestamps & Topics The following timestamps are approximations: · [01:25] – Active Ingredients: Listening, strategy and decision-making as Ahlgrimm’s leadership formula · [03:13] – Decisiveness: Why Ahlgrimm calls himself an “80% guy” over endless analysis · [27:28] – Behind Glass: What full transparency demands of CDMO leaders · [34:56] – Trust: Why it takes years to build and one event to destroy · [43:39] – Startup Scarcity: Building a gene therapy CDMO from nothing during Covid · [56:10] – Advice: What Ahlgrimm would tell the next generation of life science leaders Resources · Follow Joerg Ahlgrimm on LinkedIn: https://www.linkedin.com/in/joerg-ahlgrimm-315a925/ · Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/ Don't Miss an Episode Sign up to the Active Ingredients podcast at www.activeingredients.fraserdove.com. Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on Apple Podcasts, Amazon, Spotify, YouTube and other leading podcast platforms. Loved this episode? Share it with your friends, family, or your peers!